Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.56
-0.34 (-5.76%)
At close: May 5, 2026, 4:00 PM EDT
5.56
0.00 (0.00%)
After-hours: May 5, 2026, 4:01 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $584.1 million as of May 5, 2026. Its market cap has increased by 107.35% in one year.
Market Cap
584.10M
Enterprise Value
391.30M
1-Year Change
107.35%
Ranking
Category
Stock Price
$5.56
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $584.10M, a decrease of -31.09%. That is a compound annual growth rate of -5.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 617.60M | -12.63% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.64B |
| GRAIL | 2.22B |
| GeneDx Holdings | 1.91B |
| NeoGenomics | 1.23B |
| CareDx | 1.11B |
| OPKO Health | 830.60M |
| Castle Biosciences | 751.64M |
| Myriad Genetics | 453.33M |